Marianne K. Henderson

 

colorjpgMHenderson2015

Marianne K. Henderson

hendersm@mail.nih.gov

Title of Presentation

“Sustaining Biobanks: Insights from Business Planning across the World”

 

Date and Place

Sessions P2

 

Speaker Biography

Ms. Henderson is Senior Advisor for Division Resources, Division of Cancer Epidemiology and Genetics (DCEG) and Senior Advisor on Biobanking, Center for Global Health of the U.S. National Cancer Institute. She supports large program operations and contract management; strategic planning; and laboratory/biorepository infrastructure planning for molecular epidemiology. Since 1999, she has been active in the International Society for Biological and Environmental Repositories (ISBER) and served as ISBER President 2011-2012. Marianne is currently Chair of the ISBER Organizing Advisory Committee. She is a member of the BBMRI-LPC Scientific and Ethics Advisory Board; member of the NIH Precision Medicine Initiative – Cohort Program Biobank working group; member of the US Interagency Working Group on Scientific Collections; and Steering committee member and E&T Chair of the IARC-led LMIC Biobank and Cohort Network (BCNet); Ms. Henderson is actively involved in large-scale human biospecimen management process improvements in operations, handling, technology transfer, sustainability and repository automation.

 

Abstract

Biobanking is coming of age around the world. As biobanking has become recognized as a key infrastructure it has become clear that high quality and long-term sustainable biobanks across the world must be supported by robust business planning. The planning must engage the key stakeholders, i.e. donor / patients, biobank employees, researchers, funders, institutions and others. Professional business planning is based on sound and realistic market research and focused not on mere numbers of samples but rather on quality in all aspects of biobanking and first and foremost on customers’ needs. A stronger emphasis on financial (e.g. capacity shortfall), operational (e.g. accessibility and responsiveness of biobanks to requests) and social (e.g. acceptability & trust in biobanks) dimensions of sustainability must be established from the beginning. Business planning is a continuous process capturing the goals of the operations in the phases of its growth. Successful biobank management include key measurements and documentation to create a quality and valued resource for the biobank’s scientific community. Over the past several years, we have heard from biobankers from many sectors, including academia, hospital, pharma and enviro-bio, about their efforts at business planning sustainability. The presentation will address the state of business planning across the sectors engaged in biobanking focused specifically on the long-term sustainability of quality biospecimens and operations. Lessons learned from biobanks at different maturity levels and from differing sectors will be shared to invoke discussion at the EBW.